2022 Corporate Social Responsibility Report

Company: FOSUN PHARMA (2196)
Year: 2022
Published: 2023-04-21
Status: Processed
View Report

Extracted ESG KPIs

KPIs are organized by ESG aspects.

The types of emissions and respective emissions data.

Indicator Unit 2016 2017 2018 2019 2020 2021 2022 2025 2030 January 2022 Report Pages
Ammonia nitrogen (ton/year) ton/year 60.55 84.6 254 350 88.5 146 175 106
Ammonia nitrogen emission t/year 88 146 175 124
Ammonia nitrogen intensity kg/RMB1000.00 of output value 0.0414 0.262 0.102 0.046 0.033 0.038 0.025 0.025 0.022 93
COD (ton/year) ton/year 490 581 847 778 885 704 841 106
COD emission t/year 655 704 841 124
COD emission intensity kg/RMB 10000 of output value 0.22 0.18 0.19 124
COD emission intensity (kg/ RMB10000 of output value) kg/RMB10000 of output value 0.33 0.27 0.34 0.27 0.22 0.18 0.191 106
COD emission intensity (kg/RMB10000 of output value) kg/RMB10000 of output value 0.18 0.191 106
COD emissions intensity kg/RMB1000.00 of output value 0.33 0.45 0.34 0.27 0.22 0.18 0.19 0.19 0.18 93
Emission concentration of nitrogen oxides after gas boiler renovation at Wanbang Folon Green Factory of Xingtai City below 30mg/m³ 95
Emission of particles t/year 37 25 30 124
Intensity of nitrogen oxides (g/RMB10000 of output value) g/RMB10000 of output value 46.61 46.45 108
Intensity of particles (g/RMB10000 of output value) g/RMB10000 of output value 6.45 6.9 108
Intensity of sulfur dioxide (g/RMB10000 of output value) g/RMB10000 of output value 25.91 26.91 108
Nitrogen oxide emission intensity g/RMB 10000 of output value 46.61 46.45 124
Nitrogen oxide emissions t/year 158 182 204 124
Nitrogen oxides (ton/year) ton/year 101 204 108
Non-methane total hydrocarbons (ton/year) ton/year 42.9 40.8 108
Particle emission intensity g/RMB 10000 of output value 6.45 6.9 124
Particles (ton/year) ton/year 25 30 108
Qualified rate of VOCs emission 100% 100% 100% 124
Sulfur dioxide emission intensity g/RMB 10000 of output value 25.91 26.91 124
Sulfur oxides (ton/year) ton/year 25 118 108
VOC emissions control rate 100% VS 100% 100% VS 100% 108

Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2016 2017 2018 2019 2020 2021 2022 2025 2030 Report Pages
Ammonia nitrogen emission intensity kg/RMB 10000 of output value 0.03 0.038 0.04 124
Ammonia nitrogen emission intensity (kg/ RMB10000 of output value) kg/RMB10000 of output value 0.041 0.039 0.102 0.046 0.021 0.038 0.04 106
Ammonia nitrogen emission intensity (kg/RMB10000 of output value) kg/RMB10000 of output value 0.038 0.04 106
Annual GHG emissions (Fosun Pharma Group) tons 949469 101
Carbon Emission Intensity (tons/RMB10000 revenue) tons/RMB10000 revenue 0.23 0.254 98
Carbon emission intensity t/RMB 10000 of output value, t/RMB10000 operating income 0.6 0.54 0.41 0.35 0.27 0.23 0.22 0.22 0.2 92, 124
Carbon emission intensity (Fosun Pharma Group) ton/RMB10000 of output value 0.6 0.54 0.41 0.35 0.27 0.23 0.22 101
Direct GHG emissions (Fosun Pharma Group) tons 289044 101
Direct carbon emission (Fosun Pharma Group) %, ton 396062 380642 224552 307856 289044 101
GHG emissions from enterprises in the PRC (Fosun Pharma Group) tons 831000 101
GHG emissions from overseas enterprises (Fosun Pharma Group) tons 119000 101
Indirect energy GHG emissions (Fosun Pharma Group) tons 659631 101
Indirect energy carbon emission (Fosun Pharma Group) %, ton 389265 376563 602236 591537 69.47 101
Other indirect GHG emissions (Fosun Pharma Group) tons 794 101
Other indirect carbon emission (Fosun Pharma Group) %, ton 1044 938 1070 899 794 101
Sulfur dioxide emissions t/year 105 101 118 124
Total carbon emissions t/year 827858 900112 949469 124
Total carbon emissions (Fosun Pharma Group) ton 746179 822786 786371 758143 827858 800112 949469 101
carbon reduction by Aleph tons 980 100
carbon reduction by Chemo Biopharma tons 598 100
carbon reduction by Dongting Pharma tons 160 100
carbon reduction by Eye Pharma (Shandong base) tons 232 100
carbon reduction by Eye Pharma (Suzhou base) tons 260 100
carbon reduction by Gland Pharma tons 930 100
carbon reduction by Guilin Pharma tons 1683 100
carbon reduction by Heoin Pharma tons 96 100
carbon reduction by Huayin Medical tons 5 100
carbon reduction by Red Flag Pharma tons 150 100
carbon reduction by Sugan Zhongyou tons 228 100
carbon reduction by Wanbang Follon tons 43 100
carbon reduction by Wanbang Jinqiao tons 317 100
carbon reduction by Wanbang Pharma tons 825 100
carbon reduction by Xingxing Rehabilitation tons 97 100
carbon reduction by Yao Pharma (Renhe) tons 1143 100
carbon reduction by Yao Pharma (Shulu) tons 941 100
carbon reduction by Zhuhai Pharma tons 746 100

Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2016 2017 2018 2019 2020 2021 2022 2025 Report Pages
Hazardous waste t/year 5914.5 5953.7 7567.7 124
Hazardous waste (Fosun Pharma Group) ton 1626.8 2396.9 2683.2 4320.8 5914.5 5953.7 7567.7 110
Hazardous waste intensity kg/RMB 10000 of output value, kg/RMB10000 of output value 1.11 1.29 1.51 1.07 1.95 1.53 1.72 3.1 92, 110, 124
Total waste (Fosun Pharma Group) ton 80848 88967 85797 73458 49486 66328 69147 110
Total wastewater discharge (ton/year) ton/year 6785400 7358900 7561700 5097403 5104933 7497581 7523574 106

Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2016 2017 2018 2019 2020 2021 2022 2025 2030 Report Pages
Glass consumed by Fosun Pharma Group ton 5647 11051 6210 6810 5318 112
Paper consumed by Fosun Pharma Group ton 8341 8550 1100 9873 9629 112
Percentage of renewable materials consumed by Fosun Pharma Group % 46.7 36.4 9.4 47.6 49.7 112
Recycling rate 48.9% 104
Sewage discharge intensity t/RMB 10000 of output value, ton/RMB1000.00 of output value 4.64 3.95 3.04 2.48 2.15 1.92 1.71 1.84 1.75 93, 124
Sewage discharge intensity (ton/ RMB10000 of output value) ton/RMB10000 of output value 4.64 3.61 3.54 2.48 2.15 1.92 1.71 106
Sewage discharge intensity (tons/RMB10000 of output value) tons/RMB10000 of output value 1.92 1.71 106
Total renewable materials consumed by Fosun Pharma Group ton 8521 8573 1181 9980 9669 112
Total waste intensity kg/RMB 10000 of output value, kg/RMB10000 of output value 55.27 48.34 36.36 25.74 16.26 17.01 15.72 3.17 92, 110, 124
Total waste volume t/year 49286 66328.4 69147.4 124
Wood consumed by Fosun Pharma Group ton 180 22 181 17 40 112

Description of emissions target(s) set and steps taken to achieve them.

Indicator Unit 2017 2018 2019 2020 2021 2021-2025 Annual average 2022 2025 Report Pages
Carbon Emission Intensity reduction target for 2025 (compared with 2020) tons/RMB 10000 revenue 0.23 98
Carbon emission reduction by purchasing green electricity tons 8825 2
Carbon emission reduction from energy-saving projects (10000 tons) 10000 tons 0.79 0.94 98
Carbon reduction of energy-saving project ton 5.995 4.638 7.399 7.916 9.433 6 92
Carbon reduction through energy-saving and emission-reduction measures tons 9433 2
Total carbon reduction from green power purchase by all member enterprises thousand tons of carbon 16 99
Total carbon reduction from green power purchase by three member enterprises (2022) thousand tons of carbon 8.825 99
carbon emissions reduced tons 9433 100

Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.

Indicator Unit 2022 Report Pages
Carelife Pharma: annual reduction of packaging materials used in drums through replacement tons 800 112
Carelife Pharma: annual reduction of packaging materials used in drums through technical depth and scope expansion tons 128 112

Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2016 2017 2018 2019 2020 2021 2022 2025 2030 Report Pages
Comprehensive energy consumption GJ/year 7655768 8048743 8368603 124
Comprehensive energy consumption intensity GJ/RMB 10000 of output value, GJ/RMB100.00 of output value 2.53 2.06 1.9 102, 124
Comprehensive energy consumption intensity (GJ/RMB 10000 revenue) GJ/RMB 10000 revenue 2.48 2.43 98
Diesel (Fosun Pharma Group) % 0.41 101
Diesel consumption in healthcare services segment litre 51529 102
Diesel consumption in medical devices and medical diagnosis segment litre 37874 102
Diesel consumption in pharmaceutical manufacturing segment litre 1405435 102
Energy consumption intensity GJ/RMB10000 operating income 4.43 3.51 3.11 2.65 2.53 2.06 1.9 2.29 2.2 92
External energy consumption GJ/year 11254 102
Fuel oil (Fosun Pharma Group) % 0.81 101
Fuel oil consumption in healthcare services segment kg 15146 102
Fuel oil consumption in pharmaceutical manufacturing segment kg 2495212 102
Gasoline (Fosun Pharma Group) % 0.08 101
Gasoline consumption in healthcare services segment litre 153120 102
Gasoline consumption in medical devices and medical diagnosis segment litre 50288 102
Gasoline consumption in pharmaceutical manufacturing segment litre 158042 102
Green electricity purchased kWh 16920000 2
Internal energy consumption GJ/year 8357349 102
Liquefied (Fosun Pharma Group) % 0.01 101
Liquefied gas consumption in medical devices and medical diagnosis segment kg 4960 102
Liquefied gas consumption in pharmaceutical manufacturing segment kg 36759 102
Natural gas (Fosun Pharma Group) % 4.64 101
Natural gas consumption in healthcare services segment m³ 1315701 102
Natural gas consumption in pharmaceutical manufacturing segment m³ 19079862 102
Number of member enterprises honored as municipal, provincial or national green plants and passed energy management system certification 7 99
Number of member enterprises that passed energy management system certification 2 99
Percentage of non-renewable materials consumed by Fosun Pharma Group % 53.3 63.6 44.6 52.4 50.3 112
Purchased green power (Fosun Pharma Group) degrees 15705735 101
Purchased new energy (Fosun Pharma Group) degrees 12717883 101
Purchased steam (Fosun Pharma Group) % 23.27 101
Purchased thermal power (Fosun Pharma Group) % 64.2 101
Raw coal (Fosun Pharma Group) % 24.75 101
Raw coal consumption in pharmaceutical manufacturing segment ton 112597 102
Steam consumption in medical devices and medical diagnosis segment ton 116981 102
Steam consumption in pharmaceutical manufacturing segment ton 676147765 102
Total diesel consumption litre 1494838 102
Total electricity consumption kWh/year 713527824 102
Total electricity consumption in healthcare services segment kWh/year 60817890 102
Total electricity consumption in medical devices and medical diagnosis segment kWh/year 13198230 102
Total electricity consumption in pharmaceutical manufacturing segment kWh/year 693511705 102
Total energy consumption GJ/year 8368053 102
Total fuel oil consumption kg 2510358 102
Total gasoline consumption litre 361450 102
Total generation of internal photovoltaic power generation systems (Fosun Pharma Group) degrees 1374733 101
Total green power purchased by all member enterprises million kilowatts 26.59 99
Total green power purchased by three member enterprises (2022) million kilowatts 16.92 99
Total liquefied gas consumption kg 41719 102
Total natural gas consumption m³ 20395563 102
Total power generated by internal photovoltaic power generation system (2022) million kilowatts 1.375 99
Total raw coal consumption ton 112597 102
Total steam consumption ton 676264746 102
purchased steam saved by Eye Pharma (Suzhou base) tons 150 100
purchased steam saved by Wanbang Jinqiao tons 150 100
purchased steam saved by Wanbang Pharma tons 400 100
purchased steam saved by Zhuhai Pharma tons 1000 100

Water consumption in total and intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2016 2017 2018 2019 2020 2021 2022 2025 2030 December 2021 January 2022 Report Pages
Total amount of recycled and reused water tons 10804225 104
Total sewage discharge t/year 6505479 7497581 7523754 124
Total water consumption m³/year 8769376 9515697 9959415 9527927 9381818 10521811 10545581 104, 124
Total water saving m³ 338000 104
Water consumption intensity m³/RMB 10000 of output value, m³/RMB1000.00 of output value, m³/RMB10000 of output value 5.99 5.14 3.99 3.33 3.1 2.7 2.4 2.65 2.39 93, 104, 124
Water consumption intensity (indicator vs. actual) m³/RMB10000 of output value 3.01 VS 2.70 2.92 VS 2.40 104
Water consumption intensity decrease year-on-year % 11 2
Water saved by purified water preparation system at Wanbang Pharma Green Factory of Jiangsu Province tons of water annually 1299 95
Water saved by recycling of reclaimed water at Wanbang Folon Green Factory of Xingtai City tons of water per year 2100 95

Description of energy use efficiency target(s) set and steps taken to achieve them.

Indicator Unit 2022 2025 August 2018 December 2020 December 2021 January 2021 January 2022 Report Pages
Comprehensive energy consumption intensity reduction target for 2025 (compared with 2020) GJ/RMB 10000 revenue 2.29 98
Electricity consumption reduced by photovoltaic power plant and U-shaped dehumidification heat pipes at Wanbang Pharma Green Factory of Jiangsu Province kWh per year 987800 95
Electricity saved kWh 8860000 2
Electricity saved by air-conditioning system at Wanbang Pharma Green Factory of Jiangsu Province kWh of electricity per year 120400 95
Electricity saved by energy-saving measures at Eye Pharma Green Factory of Jiangsu Province kWh per year 300000 95
Electricity saved by energy-saving renovation at Wanbang Folon Green Factory of Xingtai City kWh of electricity per year 158000 95
Electricity saved by maglev energy-saving units and equipment at Guilin Pharma Green Factory of Guangxi Zhuang Autonomous Region kWh per year 340000 95
Electricity saved by photovoltaic power generation system and energy-saving dehumidification heat pipes at Zhaohui Pharma National Green Factory kWh per year 595000 95
FOPEX (Fosun Pharma Operation Excellence) annual cost saving million RMB 110 2
Natural gas saved m³ 968000 2
Natural gas saved by air-conditioning system at Wanbang Pharma Green Factory of Jiangsu Province cubic meters of natural gas annually 43200 95
Natural gas saved by maglev energy-saving units and equipment at Guilin Pharma Green Factory of Guangxi Zhuang Autonomous Region cubic meters per year 500000 95
Outsourced steam saved tons 4700 2
Steam saved by energy-saving measures at Eye Pharma Green Factory of Jiangsu Province tons per year 150 95
Steam saved by photovoltaic power plant and U-shaped dehumidification heat pipes at Wanbang Pharma Green Factory of Jiangsu Province tons per year 400 95
Total reduction of energy consumption GJ 84052 102
electricity saved million kWh 8.86 100
electricity saved by Chemo Biopharma kWh 850000 100
electricity saved by Dongting Pharma kWh 138000 100
electricity saved by Eye Pharma (Shandong base) kWh 262000 100
electricity saved by Eye Pharma (Suzhou base) kWh 300000 100
electricity saved by Gland Pharma kWh 1028000 100
electricity saved by Guilin Pharma kWh 1142000 100
electricity saved by Heoin Pharma kWh 80000 100
electricity saved by Huayin Medical kWh 6000 100
electricity saved by Red Flag Pharma kWh 23000 100
electricity saved by Sugan Zhongyou kWh 324000 100
electricity saved by Wanbang Follon kWh 49000 100
electricity saved by Wanbang Jinqiao kWh 380000 100
electricity saved by Wanbang Pharma kWh 987000 100
electricity saved by Xingxing Rehabilitation kWh 138000 100
electricity saved by Yao Pharma (Renhe) kWh 768000 100
electricity saved by Yao Pharma (Shulu) kWh 1789000 100
electricity saved by Zhuhai Pharma kWh 596000 100
natural gas saved thousand m³ 96.8 100
natural gas saved by Dongting Pharma thousand m³ 40 100
natural gas saved by Guilin Pharma thousand m³ 50 100
natural gas saved by Heoin Pharma thousand m³ 25 100
natural gas saved by Red Flag Pharma thousand m³ 63 100
natural gas saved by Yao Pharma (Renhe) thousand m³ 34.2 100
purchased steam saved tons 4700 100
purchased steam saved by Aleph tons 3000 100

Description of whether there is any issue in sourcing water that is fit for purpose, water efficiency target(s) set and steps taken to achieve them.

Indicator Unit 2022 2025 Report Pages
Water consumption intensity target for 2025 m³/RMB10000 of output value 2.65 104
Water saved tons 338000 2

Total packaging material used for finished products (in tonnes) and, if applicable, with reference to per unit produced.

Indicator Unit 2018 2019 2020 2021 2022 Report Pages
Metal consumed by Fosun Pharma Group ton 822 353 168 461 401 112
Non-renewable materials consumed by Fosun Pharma Group ton 9725 14973 9897 10903 9768 112
Packaging materials reused externally and the recycling amount tons 878 112
Packaging materials reused externally as a percentage of total packaging materials % 4.52 112
Plastic consumed by Fosun Pharma Group ton 2432 2715 1841 3054 3517 112
Rubber consumed by Fosun Pharma Group ton 824 854 468 578 532 112
Total packaging materials consumed by Fosun Pharma Group ton 18246 23545 12608 20793 19437 112

Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.

Indicator Unit 2020 2021 2022 Report Pages
Investment in environmental protection RMB 10000 12079 15285 13872 124
Investment in environmental protection, safety, and health million RMB 240 2
Number of ongoing projects Over 240 Over 260 122

Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.

Indicator Unit 2020 2021 2022 Report Pages
Disabled employees (Fosun Pharma Group) 72 83 89 82
Female employees (Fosun Pharma Group) 15461 17421 18614 82
Holding member hospitals with authorized beds 6333 2
Job vacancies provided worldwide 38399 2
Minority employees (Fosun Pharma Group) 934 1117 2107 82
Number of employees aged 16–20 29 90 31 73
Number of employees aged 21–30 9828 12157 12475 73
Number of employees aged 31–40 12584 14042 15148 73
Number of employees aged 41–50 6383 6768 6871 73
Number of employees aged 51–55 1953 1848 2103 73
Number of employees aged 56–60 1118 1094 1283 73
Number of employees aged above 61 363 280 488 73
Number of employees in Central China 5100 73
Number of employees in Eastern China 12796 73
Number of employees in Hong Kong, Macau and Taiwan 19 73
Number of employees in Northeast China 2150 73
Number of employees in Northern China 1786 73
Number of employees in Northwest China 269 73
Number of employees in Southern China 6949 73
Number of employees in Southwest China 2904 73
Number of employees overseas 6426 73
Number of employees with Doctor's degree 411 452 586 73
Number of employees with Junior college student degree 8516 9410 9791 73
Number of employees with Master's degree 3613 4399 4989 73
Number of employees with Secondary school student and below 8389 8256 7442 73
Number of employees with Undergraduate degree 11329 13762 15591 73
Number of female employees in Central China 2122 73
Number of female employees in Eastern China 7057 73
Number of female employees in Hong Kong, Macau and Taiwan 11 73
Number of female employees in Northeast China 1021 73
Number of female employees in Northern China 882 73
Number of female employees in Northwest China 117 73
Number of female employees in Southern China 4604 73
Number of female employees in Southwest China 1520 73
Number of female employees overseas 1285 73
Number of male employees in Central China 2978 73
Number of male employees in Eastern China 5739 73
Number of male employees in Hong Kong, Macau and Taiwan 8 73
Number of male employees in Northeast China 1129 73
Number of male employees in Northern China 904 73
Number of male employees in Northwest China 152 73
Number of male employees in Southern China 2345 73
Number of male employees in Southwest China 1384 73
Number of male employees overseas 5141 73
Number of overseas employees 6426 73
Operating revenue RMB 100 million 390.11 439.52 122
Overseas employees 6426 2
Proportion of disabled employees (Fosun Pharma Group) 0.22% 0.23% 0.23% 82
Proportion of female employees (Fosun Pharma Group) 47.93% 48.02% 48.48% 82
Proportion of minority employees (Fosun Pharma Group) 2.90% 3.08% 5.49% 82
Total employees (Fosun Pharma Group) 32258 36279 38399 82
Total number of employees (age breakdown) 32258 36279 38399 73
Total number of employees (education breakdown) 32258 36279 38399 73

Employee turnover rate by gender, age group and geographical region.

Indicator Unit 2020 2021 2022 Report Pages
Operating profit RMB 100 million 63.03 46.57 122
Outflow rate (Fosun Pharma Group) 18.76% 21.01% 21.28% 82

Number and rate of work-related fatalities occurred in each of the past three years including the reporting year.

Indicator Unit 2016 2017 2018 2019 2020 2021 2022 Report Pages
LTI rate per million working hours per million working hours 0.58 0.415 0.226 0.343 0.313 0.17 0.101 86
Loss rate (Fosun Pharma Group) 15.40% 17.14% 15.59% 82
Loss time injury rate per million man-hours 0.313 0.17 0.101 124
Major injury rate per million working hours per million working hours 0.22 0.03 0.038 86
Minor injury case rate for Fosun Pharma Group (total) 0.101 86
Minor injury case rate for Pharmaceutical manufacturing segment 0.146 86
Minor injury rate per million working hours per million working hours 0.36 0.385 0.188 0.343 0.28 0.17 0.101 86
Number of recordable incidents (RI) for Fosun Pharma Group (total) 14 86
Number of recordable incidents (RI) for Pharmaceutical manufacturing segment 10 86
Occupational hazard exposure rate 12.33% 15.16% 15.27% 124
RI rate for Fosun Pharma Group (total) 0.202 86
RI rate for Pharmaceutical manufacturing segment 0.291 86
RI rate per million working hours per million working hours 1.05 0.915 0.433 0.395 0.494 0.355 0.202 86
Recordable injury rate per million man-hours 0.494 0.355 0.202 124

Lost days due to work injury.

Indicator Unit 2022 Report Pages
Lost day for Fosun Pharma Group (total) 245 86
Lost day for Pharmaceutical manufacturing segment 245 86
Lost time injury rate (LTI rate) for Fosun Pharma Group (total) 0.101 86
Lost time injury rate (LTI rate) for Pharmaceutical manufacturing segment 0.146 86

Description of occupational health and safety measures adopted, and how they are implemented and monitored.

Indicator Unit 2020 2021 2022 Report Pages
Average hours of EHS training per person for Fosun Pharma Group hour 14.99 13.97 15.37 80
Investment in health and safety RMB 10000 6186 8192 10177.8 124
Lost time injury rate (LTI rate) decrease compared to 2021 -40.6% 86
Total EHS training hours hours 434130 391582 468731 124
Total EHS training person-times 158521 212253 274444 124
Total number of person-times of EHS training for Fosun Pharma Group time 158521 212523 274444 80
Total number of person-times of EHS training for Fosun Pharma Group (all segments) time 274444 80
Total number of person-times of EHS training for Fosun Pharma Group, Healthcare service segment time 7383 80
Total number of person-times of EHS training for Fosun Pharma Group, Medical devices and diagnosis segment time 22126 80
Total number of person-times of EHS training for Fosun Pharma Group, Pharmaceutical manufacturing segment time 244933 80

The percentage of employees trained by gender and employee category (e.g. senior management, middle management).

Indicator Unit 2020 2021 2022 Report Pages
People with black belt cultivated 20 2
People with green belt cultivated 513 2
R&D expenditure million RMB 5885 2
R&D expenditure (including capitalized investment expenses) RMB 100 million 49.78 58.85 122
R&D expenditure year-on-year increase % 18.22 2
R&D staff 2849 3646 122
Training for Senior Management - Number of trainees Person 482 258 559 75
Training for Senior Management - Total training time Hour 20712 14016 18695 75
Training for employees other than senior management - Number of trainees Person 30260 27982 27250 75
Training for employees other than senior management - Total training time Hour 646849 656078 1358624 75

The average training hours completed per employee by gender and employee category.

Indicator Unit 2020 2021 2022 Report Pages
Average Training Hours Per Person - All employees hours/person 21 19 49.5 75
Average Training Hours Per Person - Female employees hours/person 20 19 57.2 75
Average Training Hours Per Person - Male employees hours/person 21 20 43.9 75
Average hours per person of EHS training for Fosun Pharma Group (all segments) hour 15.37 80
Average hours per person of EHS training for Fosun Pharma Group, Healthcare service segment hour 2.4 80
Average hours per person of EHS training for Fosun Pharma Group, Medical devices and diagnosis segment hour 12.82 80
Average hours per person of EHS training for Fosun Pharma Group, Pharmaceutical manufacturing segment hour 20.51 80
Average times of EHS training per person for Fosun Pharma Group time 5.47 7.57 9 80
Average times per person of EHS training for Fosun Pharma Group (all segments) time 9 80
Average times per person of EHS training for Fosun Pharma Group, Healthcare service segment time 0.93 80
Average times per person of EHS training for Fosun Pharma Group, Medical devices and diagnosis segment time 13.34 80
Average times per person of EHS training for Fosun Pharma Group, Pharmaceutical manufacturing segment time 11.72 80
EHS training hours per employee 14.99 13.97 15.37 124
EHS training times per employee 5.47 7.57 9 124
Total Training Expenses RMB'000 904 837 985 75
Total hours of EHS training for Fosun Pharma Group hour 434130 391582 468731 80
Total hours of EHS training for Fosun Pharma Group (all segments) hour 468731 80
Total hours of EHS training for Fosun Pharma Group, Healthcare service segment hour 19056 80
Total hours of EHS training for Fosun Pharma Group, Medical devices and diagnosis segment hour 21248 80
Total hours of EHS training for Fosun Pharma Group, Pharmaceutical manufacturing segment hour 428427 80

Number of suppliers by geographical region.

Indicator Unit 2022 Report Pages
Number of suppliers involved in business for the year, Aleph 59 67
Number of suppliers involved in business for the year, Avanc Pharma 148 67
Number of suppliers involved in business for the year, Erye Pharma 249 67
Number of suppliers involved in business for the year, Guilin Pharma 157 67
Number of suppliers involved in business for the year, Red Flag Pharma 114 67
Number of suppliers involved in business for the year, Shanghai Henlius 164 67
Number of suppliers involved in business for the year, Wanbang Pharma 758 67
Number of suppliers involved in business for the year, Yao Pharma 537 67
Number of suppliers of domestic pharmaceutical member enterprises Overseas 391 67
Number of suppliers of domestic pharmaceutical member enterprises in Anhui 69 67
Number of suppliers of domestic pharmaceutical member enterprises in Beijing 60 67
Number of suppliers of domestic pharmaceutical member enterprises in Chongqing 135 67
Number of suppliers of domestic pharmaceutical member enterprises in Fujian 17 67
Number of suppliers of domestic pharmaceutical member enterprises in Gansu 8 67
Number of suppliers of domestic pharmaceutical member enterprises in Guangdong 113 67
Number of suppliers of domestic pharmaceutical member enterprises in Guangxi 76 67
Number of suppliers of domestic pharmaceutical member enterprises in Guizhou 4 67
Number of suppliers of domestic pharmaceutical member enterprises in Hainan 14 67
Number of suppliers of domestic pharmaceutical member enterprises in Hebei 151 67
Number of suppliers of domestic pharmaceutical member enterprises in Heilongjiang 20 67
Number of suppliers of domestic pharmaceutical member enterprises in Henan 74 67
Number of suppliers of domestic pharmaceutical member enterprises in Hong Kong, Macao, Taiwan 9 67
Number of suppliers of domestic pharmaceutical member enterprises in Hubei 67 67
Number of suppliers of domestic pharmaceutical member enterprises in Hunan 78 67
Number of suppliers of domestic pharmaceutical member enterprises in Inner Mongolia 15 67
Number of suppliers of domestic pharmaceutical member enterprises in Jiangsu 581 67
Number of suppliers of domestic pharmaceutical member enterprises in Jiangxi 51 67
Number of suppliers of domestic pharmaceutical member enterprises in Jilin 32 67
Number of suppliers of domestic pharmaceutical member enterprises in Liaoning 98 67
Number of suppliers of domestic pharmaceutical member enterprises in Ningxia 4 67
Number of suppliers of domestic pharmaceutical member enterprises in Qinghai 4 67
Number of suppliers of domestic pharmaceutical member enterprises in Shaanxi 24 67
Number of suppliers of domestic pharmaceutical member enterprises in Shandong 295 67
Number of suppliers of domestic pharmaceutical member enterprises in Shanghai 365 67
Number of suppliers of domestic pharmaceutical member enterprises in Shanxi 27 67
Number of suppliers of domestic pharmaceutical member enterprises in Sichuan 120 67
Number of suppliers of domestic pharmaceutical member enterprises in Tianjin 50 67
Number of suppliers of domestic pharmaceutical member enterprises in Tibet 3 67
Number of suppliers of domestic pharmaceutical member enterprises in Xinjiang 12 67
Number of suppliers of domestic pharmaceutical member enterprises in Yunnan 3 67
Number of suppliers of domestic pharmaceutical member enterprises in Zhejiang 195 67
Number of suppliers under annual review, Aleph 33 67
Number of suppliers under annual review, Avanc Pharma 129 67
Number of suppliers under annual review, Erye Pharma 145 67
Number of suppliers under annual review, Guilin Pharma 157 67
Number of suppliers under annual review, Red Flag Pharma 72 67
Number of suppliers under annual review, Shanghai Henlius 164 67
Number of suppliers under annual review, Wanbang Pharma 488 67
Number of suppliers under annual review, Yao Pharma 384 67

Description of practices relating to engaging suppliers, number of suppliers where the practices are being implemented, and how they are implemented and monitored.

Indicator Unit 2022 Report Pages
Number of suppliers under annual review / Number of suppliers involved in business for the year, Aleph 55.9% 67
Number of suppliers under annual review / Number of suppliers involved in business for the year, Avanc Pharma 87.2% 67
Number of suppliers under annual review / Number of suppliers involved in business for the year, Erye Pharma 58.2% 67
Number of suppliers under annual review / Number of suppliers involved in business for the year, Guilin Pharma 100.0% 67
Number of suppliers under annual review / Number of suppliers involved in business for the year, Red Flag Pharma 63.2% 67
Number of suppliers under annual review / Number of suppliers involved in business for the year, Shanghai Henlius 100.0% 67
Number of suppliers under annual review / Number of suppliers involved in business for the year, Wanbang Pharma 64.4% 67
Number of suppliers under annual review / Number of suppliers involved in business for the year, Yao Pharma 71.5% 67

Number of products and service related complaints received and how they are dealt with.

Indicator Unit 2021 2022 Report Pages
Net assets value per share attributable to shareholders of the listed company (RMB/share) RMB/share 15.29 16.68 122
Plus: Non-operating income RMB 100 million 0.29 0.35 122
Revenue year-on-year increase % 12.66 2

Description of practices relating to observing and protecting intellectual property rights.

Indicator Unit 2021 2022 Report Pages
Number of patent applications 186 249 122
Number of patents granted 62 48 122
Pipeline projects (innovative drugs, biosimilars, generic drugs, consistent evaluation) 260 2
Price reduction of medical insurance for Azvudine Tablets % 35 2

Number of concluded legal cases regarding corrupt practices brought against the issuer or its employees during the reporting period and the outcomes of the cases.

Indicator Unit 2021 2022 Report Pages
Weighted average return on net asset after deducting non-recurring profits and losses (%) % 8.58 9.39 122

Focus areas of contribution (e.g. education, environmental concerns, labour needs, health, culture, sport).

Indicator Unit 2021 2022 Report Pages
Basic earnings per share (RMB/share) RMB/share 1.85 1.43 122
Basic earnings per share (RMB/share) after deducting non-recurring profits and losses RMB/share 1.28 1.49 122
Income from asset disposal RMB 100 million -0.15 1.26 122
Malaria patients treated with Artesun (artesunate for injection) million 56 2
Number of malaria patients treated with self-developed innovative drug Artesun (artesunate for injection) by Fosun Pharma Group million patients 56 3
Tax payment million RMB 2317 2
Tax payments RMB 100 million 22.71 23.17 122

Resources contributed (e.g. money or time) to the focus area.

Indicator Unit 2021 2022 Report Pages
Investment income RMB 100 million 46.24 43.78 122
Other income RMB 100 million 3.28 3.84 122
Public donations RMB 100 million 0.36 0.6 122
Revenue million RMB 43952 2
Social contribution value per share RMB 6.13 2

The types of emissions and respective emissions data.

Standard Indicator Unit 2020 2021 2022
Airborne Particulate Matter (PM) Emissions ton/year 37 25 30
NOâ‚“ Emission Intensity (By Revenue) g/RMB10000 of output value 46.61 46.45
NOâ‚“ Emissions ton/year 158 101 204
PM Emission Intensity (By Revenue) g/RMB10000 of output value 6.45 6.9
SOâ‚“ Emission Intensity (By Revenue) g/RMB10000 of output value 25.91 26.91
SOâ‚“ Emissions ton/year 25 118

Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2016 2017 2018 2019 2020 2021 2022 2025 2030
Direct GHG Emissions (Scope 1) ton 746179 822786 396062 380642 224552 307856 289044
Indirect Energy Emissions (Scope 2) ton 389265 376563 602236 591537 659631
Total GHG Emissions ton 746179 822786 786371 758143 827858 800112 949469
Total GHG Emissions Intensity (By Revenue) ton/RMB10000 0.6 0.54 0.41 0.35 0.27 0.23 0.22 0.22 0.2
Total Other Indirect Energy Emissions (Scope 3) ton 1044 938 1070 899 794

Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2016 2017 2018 2019 2020 2021 2022 2025
Total Hazardous Waste ton 1626.8 2396.9 2683.2 4320.8 5914.5 5953.7 7567.7
Total Hazardous Waste Intensity (By Revenue) kg/RMB10000 of output value 1.11 1.29 1.07 1.51 1.95 1.53 1.72 3.1

Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2016 2017 2018 2019 2020 2021 2022 2025
Glass Waste ton 5647 11051 6210 6810 5318
Non-Hazardous Waste (Domestic Waste) ton 2135
Non-Hazardous Waste Disposed ton 55756.5
Paper Waste ton 8341 8550 1100 9873 9629
Recycling Rate of Non-Hazardous Waste % 48.9
Total Non-Hazardous Waste Intensity (By Revenue) kg/RMB10000 of output value 55.27 48.34 34.36 25.74 16.26 17.01 15.72 3.17

Description of emissions target(s) set and steps taken to achieve them.

Standard Indicator Unit 2025
Reduction in GHG Intensity Compared to Last Year (By Revenue) tons/RMB 10000 revenue 0.23

Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.

Standard Indicator Unit 2022
Non-Hazardous Waste Intensity Reduction Compared to Last Year tons 928

Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2016 2017 2018 2019 2020 2021 2022 2025 2030
Comprehensive Energy Consumption Intensity (By Revenue) GJ/RMB 10000 of output value 2.53 2.06 1.9
Diesel Fuel Consumption litre 1494838
Energy Consumption Intensity (By Revenue) GJ/RMB10000 operating income 4.43 3.51 3.11 2.65 2.53 2.06 1.9 2.29 2.2
Fossil Fuel Consumption ton 112597
Gasoline Consumption litre 361450
Heating Oil Consumption kg 2510358
LPG Consumption kg 41719
Natural Gas Consumption m³ 20395563
Purchased Electricity kWh/year 713527824
Purchased Steam ton 676264746
Solar Energy kWh 1374733
Total Direct Energy Consumption GJ/year 8357349
Total Energy Consumption GJ/year 7655768 8048743 8368053
Total Indirect Energy Consumption GJ/year 11254

Water consumption in total and intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2016 2017 2018 2019 2020 2021 2022 2025 2030
Recycled Water Usage t 10804225
Total Wastewater Discharge t 6505479 7497581 7523754
Water Consumption m³ 8769376 9515697 9959415 9527927 9381818 10521811 10545581
Water Consumption Intensity (By Revenue) m³/RMB10000 5.99 5.14 3.99 3.33 3.1 2.7 2.4 2.65 2.39

Description of energy use efficiency target(s) set and steps taken to achieve them.

Standard Indicator Unit 2022
Electricity Usage Reduction Compared to Last Year kWh 8860000
Energy Consumption Reduction Compared to Last Year GJ 84052

Description of whether there is any issue in sourcing water that is fit for purpose, water efficiency target(s) set and steps taken to achieve them.

Standard Indicator Unit 2022
Water Consumption Reduction Compared to Last Year tons 338000

Total packaging material used for finished products (in tonnes) and, if applicable, with reference to per unit produced.

Standard Indicator Unit 2018 2019 2020 2021 2022
Packaging Material Consumption (Metal) ton 822 353 168 461 401
Packaging Material Consumption (Plastic) ton 2432 2715 1841 3054 3517
Packaging Material Consumption (Rubber) ton 824 854 468 578 532
Packaging Material Savings ton
Packaging Materials Consumed ton 18246 23545 12608 20793 19437
Packaging Materials Waste Recycled ton 878

Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.

Standard Indicator Unit 2020 2021 2022
Total Investment in Ecological Restoration RMB 120790000 152850000 138720000

Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.

Standard Indicator Unit 2020 2021 2022
Number of Bachelor's Degree Employees persons 11329 13762 15591
Number of Below Junior College Employees persons 8389 8256 7442
Number of Doctoral Degree Employees persons 411 452 586
Number of Employees Aged 30-50 persons 18967 20810 22019
Number of Employees Aged Above 50 persons 3434 3222 3874
Number of Employees Aged Below 30 persons 9857 12247 12506
Number of Employees in Central China persons 5100
Number of Employees in East China persons 12796
Number of Employees in Hong Kong persons 19
Number of Employees in North China persons 1786
Number of Employees in Northeast China persons 2150
Number of Employees in Northwest China persons 269
Number of Employees in Overseas persons 6426
Number of Employees in South China persons 6949
Number of Employees in Southwest China persons 2904
Number of Female Employees persons 15461 17421 18614
Number of Master's Degree Employees persons 3613 4399 4989
Number of Total Employees persons 32258 36279 38399
Percentage of Female Employees % 47.93 48.02 48.48

Employee turnover rate by gender, age group and geographical region.

Standard Indicator Unit 2020 2021 2022
Turnover Rate of Total Employees % 18.76 21.01 21.28

Lost days due to work injury.

Standard Indicator Unit 2022
Lost Days Due to Work-related Injuries days 245
Lost Time Injury Frequency Rate (LTIFR/LTIR) 0.146

Description of occupational health and safety measures adopted, and how they are implemented and monitored.

Standard Indicator Unit 2020 2021 2022
Investment in Work Safety RMB 10000 6186 8192 10177.8
Number of People Receiving Training on Work Safety person-times 158521 212523 274444
Total Hours of Safety Training for Employees hours 434130 391582 468731

The percentage of employees trained by gender and employee category (e.g. senior management, middle management).

Standard Indicator Unit 2020 2021 2022
Percentage of Trained General Employees Person 30260 27982 27250
Percentage of Trained Senior Management Person 482 258 559

The average training hours completed per employee by gender and employee category.

Standard Indicator Unit 2020 2021 2022
Average Training Hours (Female) hours/person 20 19 57.2
Average Training Hours (Male) hours/person 21 20 43.9
Average Training Hours per Employee hours/person 21 19 49.5
Total Training Hours hour 434130 391582 468731

Number of suppliers by geographical region.

Standard Indicator Unit 2022
Number of Suppliers in Hong Kong 9
Number of Suppliers in Mainland China 1795
Number of Suppliers in Overseas 391
Number of Total Suppliers 2186

Description of practices relating to observing and protecting intellectual property rights.

Standard Indicator Unit 2021 2022
Number of Patents Applied 186 249
Number of Patents Granted 62 48

Resources contributed (e.g. money or time) to the focus area.

Standard Indicator Unit 2021 2022
Total Public Welfare Donations RMB 100 million 0.36 0.6